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Controlled trials of influenza vaccine' were conducted among employees of The British Petroleum Company in the winters of I963/64 and I964/65. The results did not support the efficacy of the vaccine and its use was abandoned (Cook, I965) . The protective effects of the vaccine, if any, would be expected to be of short duration and of the order of one year. It was decided to conduct a retrospective study to test this point.
Methods
Reference to the records made it possible to send questionnaires concerning the incidence of influenza to 50I persons. The design and use of the questionnaire was similar to that of the earlier trials. After excluding a very small group, because of residence overseas, or because further influenza vaccine had been given since i964, 363 or 72% of the original number of questionnaires were available for study. They were classified as follows:
i. those who, by chance, received the inert control injection in both years, I963 and I964; 2. those who received the vaccine in the first year and the control substance in the second year; 3. those who received control substance in the first year and vaccine in the second year; 4. those who received vaccine on both occasions.
Results
The total number in each of the groups is close Table. If the vaccine possessed any lasting protective effect, the incidence of influenza should have decreased from group I to group 4. In fact, there is no significant difference between the groups and no support for any long-term protective effect from the vaccine.
